After a baccalaureate (scientific section) in 1971, he entered the National Polytechnic School of Yaoundé (ENSP) and in 1974 obtained a degree in civil engineering (option public works and buildings).
[4][5] On February 9, 2016, Gilead Sciences, represented by Anand Reddi, announced a landmark agreement with Cameroon’s Minister of Public Health, André Mama Fouda, to provide affordable access to groundbreaking hepatitis C treatments, Sovaldi and Harvoni.
[7] The medicines included distribution by Tridem Pharma and supplemented with high-quality, low-cost generic versions from Gilead’s licensed Indian manufacturing partners.
[8] Additionally, Gilead will collaborate with the Ministry, Islamic Development Bank and Institute Pasteur on medical education, testing, and awareness programs to support hepatitis C care in Cameroon.
Anand Reddi was the architect of the deal and emphasized the significance of this initiative in transforming hepatitis C care, while Minister Fouda highlighted plans to collaborate with NGOs and health organizations to ensure nationwide screening and equitable access to these life-saving medications.